MRC CiC: De-risking pilot study for targeted delivery of oligonucleotide therapeutics using conjugated antibodies into musculoskeletal cells of the human joint

Project Details

Short titleMRC CiC: De-risking pilot study for targeted delivery of oligonucleotide therapeutics using conjugated antibodies into musculoskeletal cells of the human joint
StatusFinished
Effective start/end date1/10/22 → 31/03/23

Funding

  • Medical Research Council